With the aid of monoclonal antibodies directed against a specific site on the hemagglutinin-neuraminidase surface glycoprotein, four mutants of the Kilham neurotropic strain of mumps virus were isolated. All four mutants had increased neuraminidase activity. Two mutants (M1O and M12) lost their hemagglutination capacity with human 0 erythrocytes but retained their ability to agglutinate guinea pig erythrocytes at 40C. A third mutant (Mll) showed a change in the molecular weight of the hernagglutinin-neuraminidase glycoprotein. These three mutants (M10, Mll, and M12) showed unaltered capacity to infect tissue cultures and to cause encephalitis in newborn hamsters. A fourth mutant (M13) retained its hemagglutination activity and capacity to infect Vero cell cultures but showed significantly lower neurovirulence in the suckling hamster brain than did the parental Kilham strain and the other three mutants. Both the number of infected neurons and the amount of infectious virus in the brain was reduced. On the other hand, there were no apparent differences in the occurrence of viral antigen in ependymal cells, indicating a selective change in affinity for neurons in the brain. These results suggest that certain changes in the hemagglutinin-neuraminidase glycoprotein may lead to an alteration of the neuropathogenicity of the Kilham strain of mumps virus.
Encephalitis in newborn hamsters caused by the Kilham strain of mumps has been a subject of extensive studies from the time it was first described (11, 13, 17, 34, (49) (50) (51) . The characteristics of the virus which lead to its capacity to attack the nervous system are not well understood. It has been suggested, however, that the envelope glycoproteins play an important role (19, 21, 22) as has been shown in various virus host systems, e.g., other paramyxoviruses (9, 24, 37, 41) , influenza viruses (14, 48) , and reoviruses (6, 46) . The envelope proteins of mumps virus which may be important for pathogenicity in encephalitis are the hemagglutininneuraminidase (HN) and the fusion proteins (10, 18, 29, 30) . These two proteins have been implicated in the virulence of many paramyxoviruses. In Sendai (9, 41) and Newcastle disease virus (24) infections, cleavage of the fusion protein precursor is necessary for effective infection. The HN protein has two functions, hemagglitination (HA) activity which has been considered to be responsible for the adsorption of virus to cells (3) and neuraminidase activity which probably promotes the efficient spread of virus particles from infected cells (3) . Antibodies to specific sites of measles virus hemagglutinin have been shown to alter the clinical course of encephalitis in mice (39) , and antisera to simian virus 5 HN and fusion proteins prevent the spread of infection and cell fusion, respectively (20) . Monoclonal antibodies directed against specific epitopes of viral proteins can now be produced. These can, in turn, be used to impose selective pressure on the virus replication and isolate variants resistant to the monoclonal antibodies used (16, 36, 38, 47) . For instance, this method has been used in determining the neutralizing antigen site of poliovirus (5, 23 In this study, a monoclonal antibody against a hemagglutinating site of the Kilham strain of mumps virus was utilized for the selection of mutants. The analyses of the mutants isolated led to the discovery of one which has a much lower capacity to induce encephalitis in newborn hamsters. This method seems to be promising in determining the importance of individual surface proteins in pathogenesis, as only one protein and primarily one of its epitopes is affected at a time. This is in contrast with the situation of various wild, vaccine, and laboratory strains which may show differences in many, if not the majority of proteins, thus making it difficult to determine which protein or epitope is partially or wholly responsible for certain pathogenic properties.
MATERIALS AND METHODS
Cell cultures. In all experiments, Vero cells were used. They were grown in Eagle minimal essential medium (Flow Laboratories, Irvine, Ayrshire, Scotland) supplemented with penicillin (60 ,ug/liter), streptomycin (50 ,ug/liter), and 5% inactivated newborn bovine serum (Flow Laboratories). Culture flasks (volume, 50 ml) and petri dishes (diameter, 60 mm) were purchased from NUNC, Roskilde, Denmark.
Virus and method of assay. The Kilham strain of mumps virus (13) was initially obtained from Jerry Wolinsky (University of Texas Health Science Center at Houston, Houston, Tex.) and was propagated in Vero cells. Plaque assays and purifications were performed in 34-mm petri dishes with a 3-ml overlay of 0.5% agar in HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (32) medium. For titrations of virus infectivity, 10-fold dilutions of the material were made, and 0.1-ml samples were inoculated per dish and adsorbed for 1 h. The plaques were counted 4 to 5 days after inoculation. Monoclonal antibodies. A large number of monoclonal antibodies against mumps virus has been extensively described in a separate publication (31) . One monoclonal antibody designated as 5500 was used for mutant selection. This antibody gave effective hemagglutination inhibition (HI) and neutralization of the Kilham mumps virus strain but did not react with the RW strain. Monoclonal antibodies against other epitopes of the HN glycoprotein were used for characterization of the properties of mutants obtained.
Ascites was prepared by injecting hybridoma cells into the peritoneal cavity of mice as previously described (32) . The antibody titer of the 5500 ascites used was >106 as measured with the enzyme-linked, immunosorbent assay microtiter technique (32) . The protein content of the ascites of clone 5500 was 2.0 mg/ml (12) , and the plaque reduction capacity with Kilham virus (35) . Two hours before starting the test, a medium change was performed. Each petri dish was inoculated with an equal amount of virus, ca. 100 PFU/0.1 ml in each. After regular time intervals, from 5 to 60 min, four plates were taken and washed with 10 ml of minimal essential medium; residual fluid was then removed. Subsequently, an overlay of 0.5% agar in HEPES medium with 5% newborn bovine serum was added. Five days later, the plaques were counted.
Characterization of antigen epitopes. RIPA. The radioimmunoprecipitation assay (RIPA) was done as previously described (33, 42) . Each virus mutant and the Kilham strain were inoculated onto Vero cells in 50-ml plastic flasks at a multiplicity of infection of 1 to 3 PFU per cell. After 10 to 20% of the cell layer had begun to show cytopathic effects, 60 p.Ci of [35S]methionine in 3 ml of minimal essential medium containing only 25% of the usual amount of methionine was added. Subsequent steps have been described in previous publications (33, 42) .
HI test. The HI test used here has been described previously (28, 32) . Four HA units of antigen were used in each ascites dilution in the test. The characteristics of the monoclonal antibodies used (2015, 5342, 5374, and 5500) are described in a separate publication (31) . The various antibody clones are directed against various epitopes of the HN glycoprotein. The test was performed at 4°C with guinea pig blood.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Gel electrophoresis was done as previously described (30) . The radioactively labeled extracellular virus (as in RIPA procedure) in the supernatant fluid of an extensively infected cell culture was spun on a 65%-30% sucrose gradient in Tris-hydrochloride buffer at pH 7.4 for 90 min at 24,000 rpm in a Sorvall ultracentrifuge. The interphase was then collected and diluted in Tris-hydrochloride buffer. Subsequently, the sample was pelleted in an SW40 Sorvall ultracentrifuge rotor at 25,000 rpm for 60 min. Finally, the pellet was collected in RIPA sample buffer (42); the radioactivity was then counted in a Beckman scintillator and adjusted to correct sample volumes before being mounted on a polyacryamide gel (30) .
Virus infection of animals. Locally bred newborn (<20 h old) Syrian golden hamsters were used in this experiment. (51) .
For immunofluorescence, the brains were rapidly frozen in dry ice (15) , mixed with isopentane, and stored at -70°C until used. Coronar sections, 3 ,um thick, were cut through the brains with a cryostat, fixed in cold acetone (-200C) , and 20) , and M13 (lanes 6, 11, 16, and 21). The precipitations were made against rabbit anti-mumps whole serum (RS, lanes 2 to 6), anti-HN antibody clone 5500 (lanes 7 to 11), anti-HN antibody 5342, and anti-HN antibody clone 5374. Lane 1, Molecular weight marker. There are no precipitations in lanes 8, 9, 10, and 11 in which the four mutants were reacted with antibody 5500, i.e., the one they were selected with. Antibodies 5342 and 5374 are directed against other epitopes of the HN glycoprotein. The electrophoretic mobility of the HN molecule of Mll (lanes 14 and 19) has slightly increased. The three bands in lane 20 probably only signify a breakdown of the HN molecule during the RIPA processing.
second and third weeks of life, signs of hydrocephalus appeared in all observed cases.
Initial screening with immunofluorescence revealed no difference in viral infection of brains infected with the M10, Mll, and M12 mutants compared with the Kilham strain. On the other hand, a marked difference was found between the M13 mutant and the Kilham strain. The M13 and Kilham strains were therefore subjected to a closer evaluation and comparison. Several sections from four to six brains, sampled at three time points (5, 7, and 11 days) postinfection were examined. Approximate grading of the infection was done and performed blindly under coded numbers; infection was much more extensive in the Kilham virus-infected animals (Fig. 3) . In virtually all animals infected with this strain, a widely distributed and general viral infection was seen (Fig. 4a) , but in M13-infected brains only single neurons (Fig. 4b) or small clusters of foci (Fig. 4c ) of neurons were infected. The antigen had a granular distribution in the neurons and extended into dendritic processes. The ependymal cells were involved both with Kilham and M13 strains (Fig. 4d) , and there was no apparent quantitative difference between the two.
Histologically, hamsters sacrificed 5 and 7 days after infection with the Kilham strain showed a marked infiltration of mononuclear inflammatory cells in the leptomeninges and around intracerebral vessels. There was also marked inflammation at the ependyma; many ependymal cells were degen- erated and sloughed. The choroid plexus was better preserved. There was widespread cellular necrosis in both the cerebrum and brain stem, most striking 7 days after infection. After infection with the M13 strain, the inflammatory cells infiltration was less pronounced, but cells were present both in the leptomeninges and around intracerebral vessels. Degeneration of ependymal cells and occlusion of the aqueduct was present. Cellular necrosis in the brain parenchyma was not evident. All hamsters showed marked dilatation of the ventricular system. Replication of infectious virus in animal brains. There proved to be a much greater multiplication in vivo of the Kilham strain than the M13 mutant. Titration curves (Fig. 5) indicate an initial proliferation of the M13 which had already reached its highest levels at day 2. After this, the M13 titers were stable past day 6 and then sharply decreased but remained detectable through day 16. The Kilham strain titers, on the other hand, increased through day 6, after which most animals died. Remaining survivors at days 8 and 10 showed a lowering of viral titers. The maximal virus titers present in the Kilham-infected brains were ca. 35 times greater than those infected with the M13 mutant. DISCUSSION The four mutants characterized in this study were selected by the same monoclonal antibody and thus were altered in the same epitope on the HN glycoprotein. Possibly, other slight changes in antigenic properties were detectable by monoclonal antibodies against three other epitopes. Despite the same mode of selection of the four mutants, markedly different biological properties were observed. One of the mutants (M13) altered neurovirulence, but this did not correlate with changes in other biological activities. The other three mutants showed the same capacity to cause encephalitis in newborn hamsters as did the parental strain. However, two of them (M1O and M12) lost their hemagglutinating activity for human 0 cells, and the third mutant (Mll) showed a reduction in the molecular weight of the HN glycoprotein without any apparent consequences for the neurovirulence of the virus. The severity of infection (number of infected neurons in a coronal section from the brain) was graded as follows: 1, 0 to 100; 2, 100 to 500; 3, 500 to 1,000; and 4, 21,000. Each column represents an average of four to six animals. From each animal, three to five sections were examined. P.I., Postinfection.
The altered hemagglutinating characteristics of mutants M10 and M12 can be interpreted as a result of a combined effect of increased neuraminidase activity and a less efficient interaction between the hemagglutinin and its receptor. It is of interest that all four mutants showed increased neuraminidase activity. Since the anti-HN 5500 antibodies interfere with multiple functions of the HN molecule (31), the primary change could be either at the hemagglutinin, neuraminidase, or another site, with secondary allosteric changes in one or both of these two. Thus, the role of neuraminidase in neuropathogenicity still needs to be defined (22) .
The hemagglutinating activity of various mumps strains differs slightly (2) . Most strains agglutinate fowl, guinea pig, and human erythrocytes at any temperature between 4 and 37°C. The hemagglutinating capacity of the Habel (2) mumps strain differs from others, as it only agglutinates guinea pig erythrocytes. On the other hand, marked differences in hemagglutinating activity between various strains and mu- tants have been described in other viral systems, e.g., measles (1, 45) and vaccinia (43, 44) .
The carbohydrate structure and content of the glycoproteins presumably has an effect on their function (3, 7, 40) . Achange in glycosylation as a result of a mutation could therefore contribute to changes in biological activities, such as HA, adsorption, and neurovirulence. In addition, physicochemical properties such as molecular weight could change with altered glycosylations. This is a possible reason for the increased electrophoretic mobility of the HN protein of the Mll mutant.
The observed difference in neurovirulence between the original Kilham strain and its derivative M13 indicates that the HN glycoprotein plays an important role in neurovirulence. Thus, a certain conformation of the molecule may be necessary for neurovirulence, a property retained in the mutants M10, Mll, and M12, but partially lost or destroyed in the M13 variant. It is of interest that the 5500 monoclonal antibodies which were used for selection of the mutants do not react with the RW strain of mumps; RW is known to be significantly less neurovirulent than the Kilham strain (19) . The observation that viral infection was similar in ependymal cells of both Kilham-and M13-infected brains may imply that different receptors or modes of replication are involved in the two cell types, i.e., ependyma and neurons. The ependymal infection may cause the high incidence of hydrocephalus observed in hamsters infected with the M13 mutant. Previous studies of mumps strains (19) (6, 46) . The three outer capsid proteins of these viruses have highly distinct and specialized roles. One, the cl (hemagglutinin), is responsible for binding to cell surface receptors; another, the i.tlC, determines the capacity for viral growth in intestinal tissues and its spread in the host; the third, ca3, inhibits protein and RNA synthesis. Presumably, similar determinants of pathogenicity exist in other viral systems. Such information has begun to emerge from studies on rabies virus (4) which can be rendered nonpathogenic after treatment with neutralizing monoclonal antibodies to a surface glycoprotein.
The ease with which antibody-resistant mutants appear raises several important questions about the pathogenesis of disease. First, can antibody-resistant mutants appear in vivo? Preliminary results (R. Rydbeck and A. Love, unpublished data) indicate a similar frequency of antibody-resistant mutants appearing in vivo and in vitro. This has also been found in rabies (4, 16 Consecutive mutations in this manner could be an evolutionary explanation of the diversity of viruses. Active immunization with whole virus or intact structural components would pose none of these problems, because of the polyclonal immune response involved, unless the challenging strain shared only few epitopes with the vaccine strain. Lastly, mutants could be important in passive immunization with monoclonal antibodies. Antibodies to a single site could promote resistant mutants; therefore, the consequences of such immunizations should be carefully evaluated.
This approach in elucidating determinants of pathogenicity in vivo with mutants selected with site-specific monoclonal antibodies could prove to be very useful in determining which components, particularly surface components, are the main contributors of pathogenicity and virulence. This, in turn, can provide useful information in evaluating the efficiency and dangers of vaccines or other methods which are used in the prevention and treatment of infectious disease.
